Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Murphy

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
BMC Medical Informatics and Decision Making|October 18, 2022
Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reportsNakeya Dewaswala, David Chen, Huzefa Bhopalwala, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
JACC. Advances|June 28, 2024
Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial InfarctionClaire Lin, Cian P McCarthy, Reza Mohebi, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Journal of the American College of Cardiology|October 1, 2023
Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial InfarctionCian P McCarthy, Sean P Murphy, Daniel K Amponsah, et al.
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
Plos One|April 7, 2022
The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasmAmna Zafar, Zsofia D Drobni, Matthew Lei, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
BMC Medical Informatics and Decision Making|October 18, 2022
Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reportsNakeya Dewaswala, David Chen, Huzefa Bhopalwala, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
JACC. Advances|June 28, 2024
Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial InfarctionClaire Lin, Cian P McCarthy, Reza Mohebi, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Journal of the American College of Cardiology|October 1, 2023
Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial InfarctionCian P McCarthy, Sean P Murphy, Daniel K Amponsah, et al.
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
Plos One|April 7, 2022
The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasmAmna Zafar, Zsofia D Drobni, Matthew Lei, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Pageof 8